Medicines Australia launches awareness campaign to back up its transparency requirements

6 July 2015
australia-big

Medicines Australia, the representative body for the Australian pharma industry, has launched an awareness campaign to ensure that health care professionals understand the new transparency enhancements contained in its updated code of conduct.

From October, the Industry Code of Conduct will require payments to health care professionals to be disclosed online to the public for the first time.

Tim James, chief executive of Medicines Australia, said: “Our members are proud of the work that we do to ensure that the public can continue to have confidence in our local medicines industry. Transparency is a key component of the bond of trust with the Australian public. A strong working relationship and the ongoing exchange of knowledge between the medicine makers and healthcare professionals are critical to better patient outcomes. Expert advice from experienced healthcare professionals is important to ensure vital new medicines are developed and used safely and effectively.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical